These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 19248192)
21. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily. Haag S; Holtmann G Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237 [TBL] [Abstract][Full Text] [Related]
22. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus. Triadafilopoulos G; Kaczynska M; Iwane M Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146 [TBL] [Abstract][Full Text] [Related]
23. A standardized method for measuring intercellular spaces in esophageal biopsies in patients with suspected gastroesophageal reflux disease (the intercellular space ratio). Johannessen R; Skogaker N; Halgunset J; Petersen H; Kleveland PM Scand J Gastroenterol; 2013 Nov; 48(11):1235-41. PubMed ID: 24079906 [TBL] [Abstract][Full Text] [Related]
24. 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms. Gillessen A; Beil W; Modlin IM; Gatz G; Hole U J Clin Gastroenterol; 2004 Apr; 38(4):332-40. PubMed ID: 15087692 [TBL] [Abstract][Full Text] [Related]
25. A pilot study of efficacy and safety of continuous intravenous infusion of pantoprazole in the treatment of severe erosive esophagitis. Cai Q; Barrie M; Olejeme H; Rosenberg MD Dig Dis Sci; 2008 Jun; 53(6):1500-5. PubMed ID: 17985242 [TBL] [Abstract][Full Text] [Related]
26. Long-term management of GERD in the elderly with pantoprazole. Calabrese C; Fabbri A; Di Febo G Clin Interv Aging; 2007; 2(1):85-92. PubMed ID: 18044079 [TBL] [Abstract][Full Text] [Related]
27. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group. Richter JE; Bochenek W Am J Gastroenterol; 2000 Nov; 95(11):3071-80. PubMed ID: 11095320 [TBL] [Abstract][Full Text] [Related]
28. Altered intercellular glycoconjugates and dilated intercellular spaces of esophageal epithelium in reflux disease. Solcia E; Villani L; Luinetti O; Trespi E; Strada E; Tinelli C; Fiocca R Virchows Arch; 2000 Mar; 436(3):207-16. PubMed ID: 10782878 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of health-related quality of life in gastroesophageal reflux disease patients before and after treatment with pantoprazole. de Souza Cury M; Ferrari AP; Ciconelli R; Ferraz MB; Moraes-Filho JP Dis Esophagus; 2006; 19(4):289-93. PubMed ID: 16866863 [TBL] [Abstract][Full Text] [Related]
30. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain]. Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease. van Zyl J; van Rensburg C; Vieweg W; Fischer R Digestion; 2004; 70(1):61-9. PubMed ID: 15297779 [TBL] [Abstract][Full Text] [Related]
33. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. Caro JJ; Salas M; Ward A Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776 [TBL] [Abstract][Full Text] [Related]
34. Esophageal epithelial surface in patients with gastroesophageal reflux disease: an electron microscopic study. Azumi T; Adachi K; Furuta K; Nakata S; Ohara S; Koshino K; Miki M; Morita T; Tanimura T; Ashizawa N; Kinoshita Y World J Gastroenterol; 2008 Oct; 14(37):5712-6. PubMed ID: 18837089 [TBL] [Abstract][Full Text] [Related]
35. Refractory heartburn: comparison of intercellular space diameter in documented GERD vs. functional heartburn. Vela MF; Craft BM; Sharma N; Freeman J; Hazen-Martin D Am J Gastroenterol; 2011 May; 106(5):844-50. PubMed ID: 21179012 [TBL] [Abstract][Full Text] [Related]
36. Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-h intragastric acidity and oesophageal acid exposure: a randomized study in gastro-oesophageal reflux disease patients with a history of nocturnal heartburn. Miner P; Delemos B; Xiang J; Lococo J; Ieni J Aliment Pharmacol Ther; 2010 May; 31(9):991-1000. PubMed ID: 20132153 [TBL] [Abstract][Full Text] [Related]
37. Effect of pantoprazole in older patients with erosive esophagitis. DeVault KR; Morgenstern DM; Lynn RB; Metz DC Dis Esophagus; 2007; 20(5):411-5. PubMed ID: 17760655 [TBL] [Abstract][Full Text] [Related]
38. Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease. van Malenstein H; Farré R; Sifrim D Am J Gastroenterol; 2008 Apr; 103(4):1021-8. PubMed ID: 18076734 [TBL] [Abstract][Full Text] [Related]
39. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study. Körner T; Schütze K; van Leendert RJ; Fumagalli I; Costa Neves B; Bohuschke M; Gatz G Digestion; 2003; 67(1-2):6-13. PubMed ID: 12743434 [TBL] [Abstract][Full Text] [Related]
40. Pantoprazole on-demand effectively treats symptoms in patients with gastro-oesophageal reflux disease. Scholten T; Teutsch I; Bohuschke M; Gatz G Clin Drug Investig; 2007; 27(4):287-96. PubMed ID: 17358101 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]